Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
181
Employees181
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
181
Employees181

FATE Key Statistics

Market cap
134.12M
Market cap134.12M
Price-Earnings ratio
-0.78
Price-Earnings ratio-0.78
Dividend yield
Dividend yield
Average volume
2.30M
Average volume2.30M
High today
$1.23
High today$1.23
Low today
$1.15
Low today$1.15
Open price
$1.16
Open price$1.16
Volume
1.33M
Volume1.33M
52 Week high
$5.92
52 Week high$5.92
52 Week low
$0.6611
52 Week low$0.6611

Analyst ratings

60%

of 10 ratings
Buy
40%
Hold
60%
Sell
0%

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.